AboutBusiness
HelpPrivacyTerms
RiepilogoLegale e statoCronologiaReteProprietà e organiSociBeneficiario effettivoGeografiaBilancioSalute finanziariaDocumenti
RiepilogoLegale e statoCronologiaReteProprietà e organiSociBeneficiario effettivoGeografiaBilancioSalute finanziariaDocumenti

PHARMACIE CHARRON

🇫🇷Francia•Société D'exercice Libéral À Responsabilité Limitée•Active
YoY profit / (loss) (2023 vs 2024)YoY profit / (loss)
+1%
Return on assets (net) (2024)Return on assets (net)
9,9%
CAGR profit / (loss) (2016–2024)CAGR profit / (loss)

Riepilogo

Country🇫🇷Francia
StatusActive
Registration Number81194581500017
Founded10/06/2015
Address149 Rue Abbe Pasty, Baule, 45130

Dati legali e stato

Legal FormSociété D'exercice Libéral À Responsabilité Limitée
StatusActive
Registration Date10/06/2015
Registry AuthorityINPI
Registered Capital50.000

Source: FR INPI · Last updated: 31/03/2026

Timeline (2 events)

19/05/2024

Sylvain Charron (person)

Appointed as Officer

10/06/2015

Company incorporated

Incorporation date: 2015-06-10

Rete

Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Profondità rete

Proprietà e organi

Officers & directors

Sylvain Charron

Officer

Appointed: 19/05/2024

—

Ownership Timeline

No ownership changes found

Soci (azionariato)

NomePartecipazioneVotoDal
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Beneficiario effettivo

NomePartecipazionePaeseDal
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Geografia

Sede

149 Rue Abbe Pasty

Baule

45130

Bilancio e conti

Cifre chiave dai bilanci depositati.

Convert to

2016

Profit / (loss): €63.4K

Key figures

Profit / (loss)

2016€63.358
2017€131.654
2018€140.492
2019€190.194
2020€187.986
2021€111.830
2022€299.886
2023€253.197
2024€255.819

Total assets

2016€2.093.844
2017€2.107.051
2018€2.026.390
2019€2.037.816
2020€1.964.384
2021€2.129.043
2022€2.328.013
2023€2.500.280
2024€2.584.291

Share Capital

2016€50.000
2017€50.000
2018€50.000
2019€50.000
2020€50.000
2021€50.000
2022€50.000
2023€50.000
2024€50.000
Metric201620172018201920202021202220232024
Profit / (loss)€63.358€131.654€140.492€190.194€187.986€111.830€299.886€253.197€255.819
Total assets€2.093.844€2.107.051€2.026.390€2.037.816€1.964.384€2.129.043€2.328.013€2.500.280€2.584.291
Share Capital€50.000€50.000€50.000€50.000€50.000€50.000€50.000€50.000€50.000

Documenti

Document downloads are not available yet for French companies.

Comptes annuels

Accounts for the accounting period ending on: 30/09/2024

Filed: 30/05/2025

Formalité RNE — création 2015-06-10

19/05/2024

Comptes annuels

Accounts for the accounting period ending on: 30/09/2023

Filed: 13/05/2024

Comptes annuels

Accounts for the accounting period ending on: 30/09/2022

Filed: 13/04/2023

Comptes annuels

Accounts for the accounting period ending on: 30/09/2021

Filed: 20/04/2022

Comptes annuels

Accounts for the accounting period ending on: 30/09/2020

Filed: 30/03/2021

Comptes annuels

Accounts for the accounting period ending on: 30/09/2019

Filed: 30/04/2020

Document AI

Coming soon

Companexia Document AI

Ask questions about filings and extracts—our AI will read the documents and answer in context.

Comptes annuels

Accounts for the accounting period ending on: 30/09/2018

Filed: 13/03/2019

Comptes annuels

Accounts for the accounting period ending on: 30/09/2017

Filed: 25/04/2018

Showing 1–10 of 11

1 / 2

Altre aziende e persone

🇮🇪KILDALE LIMITED🇮🇪BRAMBURY LIMITED🇮🇪CLOVERWOOD LIMITED🇬🇧COOPER, LynnemarieVISHWAS SESHADRI PHD,MBACAROLINE MARIE-THERESE JACQUELINE SIMONE THOMAS
+19,1%
YoY total assets (2023 vs 2024)YoY total assets
+3,4%
CAGR total assets (2016–2024)CAGR total assets
+2,7%

Financial Health

Derived ratios from annual accounts. Values are omitted when data is missing or not meaningful.

Growth

YoY profit / (loss) (2016 vs 2017)
+107,8%
YoY total assets (2016 vs 2017)
+0,6%
YoY profit / (loss) (2017 vs 2018)
+6,7%
YoY total assets (2017 vs 2018)
-3,8%
YoY profit / (loss) (2018 vs 2019)
+35,4%
YoY total assets (2018 vs 2019)
+0,6%
YoY profit / (loss) (2019 vs 2020)
-1,2%
YoY total assets (2019 vs 2020)
-3,6%
YoY profit / (loss) (2020 vs 2021)
-40,5%
YoY total assets (2020 vs 2021)
+8,4%
YoY profit / (loss) (2021 vs 2022)
+168,2%
YoY total assets (2021 vs 2022)
+9,3%
YoY profit / (loss) (2022 vs 2023)
-15,6%
YoY total assets (2022 vs 2023)
+7,4%
YoY profit / (loss) (2023 vs 2024)
+1%
YoY total assets (2023 vs 2024)
+3,4%
CAGR profit / (loss) (2016–2024)
+19,1%
CAGR total assets (2016–2024)
+2,7%

Efficiency & returns

Return on assets (net) (2016)
3%
Return on assets (net) (2017)
6,2%
Return on assets (net) (2018)
6,9%
Return on assets (net) (2019)
9,3%
Return on assets (net) (2020)
9,6%
Return on assets (net) (2021)
5,3%
  1. Home
  2. –Francia
  3. –Baule
  4. –PHARMACIE CHARRON
Return on assets (net) (2022)
12,9%
Return on assets (net) (2023)
10,1%
Return on assets (net) (2024)
9,9%